Terry-Ann Burrell, Chief Financial Officer at Beam Therapeutics Inc. (BEAM), sold 40,472 shares at $45.01 ($1.8M) on 2023-01-24, disclosed to the SEC on 2023-01-25.
Open-market sale of $1.8M BEAM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.02 | 5,426 | $244K | 13.4% |
| 2 | $45.02 | 5,426 | $244K | 13.4% |
| 3 | $45.01 | 14,810 | $667K | 36.6% |
| 4 | $45.01 | 14,810 | $667K | 36.6% |
| Total | $45.01 avg | 40,472 | $1.8M | 100% |
| Filing → |
| BEAM | SELL | 2023-04-05 | $276K | — | Filing → |
| BEAM | SELL | 2023-01-30 | $3.3M | — | Filing → |
| BEAM | SELL | 2023-01-20 | $4.3M | — | Filing → |